New therapies in chronic prostatitis

Current Urology Reports

Volumn 8, Issue 4, 2007, Pages 313-318

  Dhar, Nivedita Bhatta ^b   Shoskes, Daniel A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; CALCIUM CHELATING AGENT; CERNITIN; CIPROFLOXACIN; ENZYME; FINASTERIDE; GABAPENTIN; GRAMINEX; LEVOFLOXACIN; MACROLIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PENTOSAN POLYSULFATE; PLACEBO; POLLEN EXTRACT; POLTIT; PROSTA Q; PROSTAT; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROFECOXIB; SABAL EXTRACT; STEROID; SULFANILAMIDE DERIVATIVE; TAMSULOSIN; TERAZOSIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ALGORITHM; CHRONIC PROSTATITIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG PENETRATION; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; GASTROINTESTINAL SYMPTOM; HUMAN; LOW DRUG DOSE; MASSAGE; NONHUMAN; PATIENT CARE; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; PHYTOTHERAPY; PKA; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ALGORITHMS; CHRONIC DISEASE; HUMANS; MALE; PELVIC PAIN; PROSTATITIS; SYNDROME;

EID: 34547471081     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0078-5     Document Type: Review

References (54)

1. Litwin MS: A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology 2002, 60:14-18.
2. Turner JA, Ciol MA, Von Korff M, Berger R: Validity and responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2003, 169:580-583.
3. Propert KJ, Litwin MS, Wang Y, et al.: Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 2006, 15:299-305. The CPSI was designed to quantify symptoms in men with CPPS. This study shows that it is also responsive to therapy.
4. Propert KJ, McNaughton-Collins M, Leiby BE, et al.: A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2006, 175:619-623. First major collaborative study of men with CPPS. Over 3 years about one third of patients had improvement in symptoms. There was significant reduction in quality of life.
5. Wagenlehner FM, Weidner W, Sorgel F, Naber KG: The role of antibiotics in chronic bacterial prostatitis. Int J Antimicrob Agents 2005, 26:1-7.
6. Naber KG, Sorgel F: Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 2003, 35:331-335.
7. Nickel JC, Downey J, Johnston B, et al.: Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001, 165:1539-1544.
8. Weidner W, Ludwig M, Brahler E, Schiefer HG: Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs 1999, 58:103-106.
9. Naber KG, Busch W, Focht J: Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. Int J Antimicrob Agents 2000, 14:143-149.
10. Jimenez-Cruz JF, Tormo FB, Gomez JG: Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. J Urol 1988, 139:967-970.
11. Hu WL, Zhong SZ, He HX: Treatment of chronic bacterial prostatitis with amikacin through anal submucosal injection. Asian J Androl 2002, 4:163-167.
12. Barbalias GA, Nikiforidis G, Liatsikos EN: Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998, 159:883-887.
13. Shoskes DA, Zeitlin SI: Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis. Prostate Cancer Prostatic Dis 1999, 2:159-162.
14. Pontari MA, McNaughton-Collins M, O'Leary MP, et al.: A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005, 96:559-565.
15. Shoskes DA, Landis JR, Wang Y, et al.: Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:542-547.
16. Yavascaoglu I, Oktay B, Simsek U, Ozyurt M: Role of ejaculation in the treatment of chronic non-bacterial prostatitis. Int J Urol 1999, 6:130-134.
17. Ullrich PM, Turner JA, Ciol M, Berger R: Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med 2005, 30:112-118. Stress has long been suspected to contribute to the syndrome of prostatitis. In this study, increased stress was associated with increased CPPS symptoms.
18. Lee JC, Muller CH, Rothman I, et al.: Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003, 169:587-588.
19. Nickel JC, Downey J, Clark J, et al.: Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003, 62:614-617.
20. Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581-589.
21. Kaplan SA, Santarosa RP, D'Alisera PM, et al.: Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 1997, 157:2234-2237.
22. Mayo ME, Ross SO, Krieger JN: Few patients with "chronic prostatitis" have significant bladder outlet obstruction. Urology 1998, 52:417-421.
23. Neal DE Jr, Moon TD: Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994, 43:460-465.
24. Nickel JC, Narayan P, McKay J, Doyle C: Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004, 171:1594-1597.
25. de la Rosette JJ, Karthaus HF, van Kerrebroeck PE, et al.: Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol 1992, 22:222-227.
26. Ishigooka M, Nakada T, Hashimoto T, et al.: Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate. Urology 2002, 59:139-144.
27. A Pontari M: Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology 2002, 60:29-33.
28. Nadler RB, Koch AE, Calhoun EA, et al.: Il-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000, 164:214-218.
29. Shahed AR, Shoskes DA: Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl 2000, 21:669-675.
30. Shahed AR, Shoskes DA: Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 2001, 166:1738-1741.
31. John H, Barghorn A, Funke G, et al.: Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol 2001, 39:72-78.
32. Galley HF, Dhillon JK, Paterson RL, Webster NR: Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line. Clin Sci (Lond) 2000, 99:405-410.
33. Canale D, Scaricabarozzi I, Giorgi P, et al.: Use of a novel non-steroidal anti-inflammatory drug, nimesulide, in the treatment of abacterial prostatovesiculitis. Andrologia 1993, 25:163-166.
34. Nickel JC, Pontari M, Moon T, et al.: A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003, 169:1401-1405.
35. Bates S, Talbot M: Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one nonresponder. Sex Transm Infect 2000, 76:398-399.
36. Palapattu GS, Shoskes DA: Resolution of the chronic pelvic pain syndrome after renal transplantation. J Urol 2000, 164:127.
37. Nickel JC, Forrest JB, Tomera K, et al.: Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005, 173:1252-1255.
38. Shoskes DA: Phytotherapy in chronic prostatitis. Urology 2002, 60:35-37.
39. Rugendorff EW, Weidner W, Ebeling L, Buck AC: Results of treatment with pollen extract (cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 1993, 71:433-438.
40. Elist J: Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 2006, 67:60-63.
41. Hollman PC, Katan MB: Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 1998, 20:237-248.
42. Guardia T, Rotelli AE, Juarez AO, Pelzer LE: Anti-inflammatory properties of plant flavonoids: effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001, 56:683-687.
43. Sato M, Miyazaki T, Kambe F, et al.: Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997, 24:1680-1684.
44. Shoskes DA: Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis. J Am Neutraceutic Assoc 1999, 2:18-21.
45. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999, 54:960-963.
46. Kaplan SA, Volpe MA, Te AE: A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004, 171:284-288.
47. Cornel EB, van Haarst EP, Schaarsberg RW, Geels J: The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol 2005, 47:607-611.
48. Anderson RU, Wise D, Sawyer T, Chan C: Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol 2005, 174:155-160. Evidence that combination of pelvic physical therapy with stress reduction can improve symptoms in men with CPPS and pelvic muscle spasm. Confirmation via a sham-controlled study is eagerly awaited.
49. Rowe E, Smith C, Laverick L, et al.: A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. J Urol 2005, 173:2044-2047.
50. Holroyd KA, O'Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208-2215.
51. Covington EC: Anticonvulsants for neuropathic pain and detoxification. Cleve Clin J Med 1998, 65(Suppl 1): SI21-S129.
52. Geramoutsos I, Gyftopoulos K, Perimenis P, et al.: Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004, 45:333-337.
53. Shoskes, DA, Thomas, KD, Gomez, E. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005, 173:474.
54. Shoskes DA, Hakim L, Ghoniem G, Jackson CL: Long-term results of multi-modal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003, 169:1406-1410.